Brain positron emission tomography in splenectomized adults with β-thalassemia intermedia: uncovering yet another covert abnormality

[1]  J. Stockman.  Neuropsychological Dysfunction and Neuroimaging Abnormalities in Neurologically Intact Adults With Sickle Cell Anemia , 2012 .

[2]  B. Bain.  Disorders of Hemoglobin: Genetics, Pathophysiology and Clinical Management , 2011 .

[3]  Khaled M Musallam,et al.  Optimal management of β thalassaemia intermedia , 2011, British journal of haematology.

[4]  J. Jankovic,et al.  Iron chelation and neuroprotection in neurodegenerative diseases , 2011, Journal of Neural Transmission.

[5]  A T Taher,et al.  Splenectomy and thrombosis: the case of thalassemia intermedia , 2010, Journal of thrombosis and haemostasis : JTH.

[6]  Khaled M Musallam,et al.  Redefining thalassemia as a hypercoagulable state , 2010, Annals of the New York Academy of Sciences.

[7]  M. Cappellini,et al.  Age‐related complications in treatment‐naïve patients with thalassaemia intermedia , 2010, British journal of haematology.

[8]  M. Cappellini,et al.  Magnetic resonance evaluation of hepatic and myocardial iron deposition in transfusion‐independent thalassemia intermedia compared to regularly transfused thalassemia major patients , 2010, American journal of hematology.

[9]  M. Cappellini,et al.  Overview on practices in thalassemia intermedia management aiming for lowering complication rates across a region of endemicity: the OPTIMAL CARE study. , 2010, Blood.

[10]  A. Beydoun,et al.  Asymptomatic brain magnetic resonance imaging abnormalities in splenectomized adults with thalassemia intermedia , 2010, Journal of thrombosis and haemostasis : JTH.

[11]  J. Krejza,et al.  Neuroimaging in assessment of risk of stroke in children with sickle cell disease. , 2010, Advances in medical sciences.

[12]  C. Cesaretti,et al.  Absence of cardiac siderosis despite hepatic iron overload in Italian patients with thalassemia intermedia: an MRI T2* study , 2010, Annals of Hematology.

[13]  D. Nathan,et al.  Sickle cell disease and stroke. , 2009, Blood.

[14]  M. Cappellini,et al.  Iron overload in thalassaemia intermedia: reassessment of iron chelation strategies , 2009, British journal of haematology.

[15]  D. Weatherall,et al.  Disorders of Hemoglobin: THE MOLECULAR, CELLULAR, AND GENETIC BASIS OF HEMOGLOBIN DISORDERS , 2009 .

[16]  M. Cappellini,et al.  Correlation of liver iron concentration determined by R2 magnetic resonance imaging with serum ferritin in patients with thalassemia intermedia , 2008, Haematologica.

[17]  R. Galanello,et al.  No evidence of cardiac iron in 20 never- or minimally-transfused patients with thalassemia intermedia , 2008, Haematologica.

[18]  M. Cappellini,et al.  Prevalence of thromboembolic events among 8,860 patients with thalassaemia major and intermedia in the Mediterranean area and Iran , 2006, Thrombosis and Haemostasis.

[19]  R. Adams,et al.  Pathophysiology and treatment of stroke in sickle-cell disease: present and future , 2006, The Lancet Neurology.

[20]  Pat M. E. Altham,et al.  3. Computer‐aided multivariate analysis (4th edn). Abdelmonem Afifi, Virginia A. Clark and Susanne May, Chapman & Hall/CRC, Boca Raton, 2004. No. of pages: xvi + 489. Price: £39.99, $79.95. ISBN: 1‐58488‐308‐1 , 2005 .

[21]  T. S. St. Pierre,et al.  Noninvasive measurement and imaging of liver iron concentrations using proton magnetic resonance. , 2005, Blood.

[22]  E. Rachmilewitz,et al.  MEDICAL PROGRESS : β-thalassemia , 2005 .

[23]  A. Thakkinstian,et al.  Relationship between hypercoagulable state and erythrocyte phosphatidylserine exposure in splenectomized haemoglobin E/β‐thalassaemic patients * , 2002, British journal of haematology.

[24]  Jacqueline A Bello,et al.  Longitudinal changes in brain magnetic resonance imaging findings in children with sickle cell disease. , 2002, Blood.

[25]  R. Zimmerman,et al.  Silent infarcts in children with sickle cell anemia and abnormal cerebral artery velocity. , 2001, Archives of neurology.

[26]  Scott T. Miller,et al.  Silent infarction as a risk factor for overt stroke in children with sickle cell anemia: a report from the Cooperative Study of Sickle Cell Disease. , 2001, The Journal of pediatrics.

[27]  L. Enos,et al.  Neuropsychologic performance in school-aged children with sickle cell disease: a report from the Cooperative Study of Sickle Cell Disease. , 2001, The Journal of pediatrics.

[28]  M. Cappellini,et al.  Venous thromboembolism and hypercoagulability in splenectomized patients with thalassaemia intermedia. , 2000, British journal of haematology.

[29]  J. Hoffman,et al.  FDG PET imaging in patients with pathologically verified dementia. , 2000, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[30]  G. Sebag,et al.  Multicenter Prospective Study of Children With Sickle Cell Disease: Radiographic and Psychometric Correlation , 2000, Journal of child neurology.

[31]  E. Giarratano,et al.  MR imaging of the brain: findings in asymptomatic patients with thalassemia intermedia and sickle cell-thalassemia disease. , 1999, AJR. American journal of roentgenology.

[32]  W. Jagust,et al.  Role of positron emission tomography in determining the extent of CNS ischemia in patients with sickle cell disease , 1999, American journal of hematology.

[33]  C. Zee,et al.  Cerebral vasculopathy in sickle cell anemia: diagnostic contribution of positron emission tomography. , 1999, Blood.

[34]  G. Perry,et al.  Iron accumulation in Alzheimer disease is a source of redox-generated free radicals. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[35]  J. De Keyser,et al.  Is positron emission tomography useful in stroke? , 1997, Acta neurologica Belgica.

[36]  Robert A. Zimmerman,et al.  Cognitive Functioning and Brain Magnetic Resonance Imaging in Children With Sickle Cell Disease , 1996, Pediatrics.

[37]  R. Zimmerman,et al.  Cognitive functioning and brain magnetic resonance imaging in children with sickle Cell disease. Neuropsychology Committee of the Cooperative Study of Sickle Cell Disease. , 1996, Pediatrics.

[38]  H. Gross,et al.  Local cerebral glucose metabolism in patients with long-term behavioral and cognitive deficits following mild traumatic brain injury. , 1996, The Journal of neuropsychiatry and clinical neurosciences.

[39]  J C Froment,et al.  Positron Emission Tomography Metabolic Data Corrected for Cortical Atrophy Using Magnetic Resonance Imaging , 1996, Alzheimer disease and associated disorders.

[40]  M. Cappellini,et al.  Thalassemia intermedia. , 1995, Haematologica.

[41]  M. Sano,et al.  Abnormal cranial magnetic resonance imaging scans in sickle-cell disease. Neurological correlates and clinical implications. , 1993, Archives of neurology.

[42]  D. Perl,et al.  Selective accumulation of aluminum and iron in the neurofibrillary tangles of Alzheimer's disease: A laser microprobe (LAMMA) study , 1992, Annals of neurology.

[43]  Mehta Rc,et al.  Physiologic imaging of the brain. , 1992 .

[44]  M. Marks,et al.  Physiologic imaging of the brain. , 1992, Current opinion in radiology.

[45]  A. Schechter,et al.  Brain glucose metabolism in neurologically normal patients with sickle cell disease. Regional alterations. , 1988, Archives of neurology.

[46]  T Jones,et al.  Measurement of regional cerebral blood flow, blood volume and oxygen metabolism in patients with sickle cell disease using positron emission tomography. , 1986, Stroke.

[47]  V. Clark,et al.  Computer-aided multivariate analysis , 1991 .